Measurement of liver elasticity (i.e., stiffness) can be used as a noninvasive alternative to liver biopsy to stage liver fibrosis, a condition afflicting hundreds of millions of patients worldwide.

Objective Non-alcoholic fatty liver disease (NAFLD) is the leading cause of end-stage liver diseases worldwide. Understanding NAFLD prevalence and trends over time at the global, regional and national ...

Many people in the UK are living with high cholesterol without realising, as the condition often has no symptoms ...

Madrigal Pharma's REZDIFFRA sees 33% Q1 2025 sales growth, strong EU progress, and promising MASH data. Read why I maintain ...

There was no association observed between lower income and increased fibrosis among New York City residents with metabolic dysfunction-associated steatohepatitis (MASH).

Six out of ten people with type 2 diabetes had fatty liver in a new study from Linköping University. Of these, only a small ...

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 30% of the general population and is ...

BackgroundProprotein convertase subtilisin/kexin type 9 (PCSK9) circulating levels are significantly associated with an increased risk of cardiovascular events. This study aimed to evaluate the ...

Imagine a condition affecting nearly one-third of the global population, often silently progressing, and deeply intertwined ...

THIS YEAR, the vibrant city of Amsterdam, the Netherlands played host to the European Association for the Study of ...

The following highlights showcase late-breaking research presented at the European Association for the Study of the Liver ...

A shocking new study shows a significant connection between type 2 diabetes and liver diseases, highlighting the increased ...